Which beta blocker?
作者信息
Breckenridge A
出版信息
Br Med J (Clin Res Ed). 1983 Apr 2;286(6371):1085-8. doi: 10.1136/bmj.286.6371.1085.
Abstract
摘要
相似文献
1
Which beta blocker?选用哪种β受体阻滞剂？
Br Med J (Clin Res Ed). 1983 Apr 2;286(6371):1085-8. doi: 10.1136/bmj.286.6371.1085.
2
[How selective are cardioselective beta-receptor blockers?].
Dtsch Med Wochenschr. 1995 Jan 5;120(1-2):45-6.
3
Beta blockers.β受体阻滞剂
Am J Nurs. 1983 Jul;83(7):1034-43.
4
Beta-adrenergic blocking agents: review and update.β-肾上腺素能阻滞剂：综述与更新
Mt Sinai J Med. 1985 Sep;52(7):553-8.
5
Beta-blockers and hypertension: carbon copies or a real choice.
Compr Ther. 1984 Sep;10(9):12-8.
6
Clinical pharmacology of beta-receptor-blocking drugs.β受体阻滞剂的临床药理学
Clin Pharmacol Ther. 1969 Nov-Dec;10(6):765-99.
7
8
[Beta-adrenergic blockers].[β-肾上腺素能阻滞剂]
Vutr Boles. 1986;25(4):14-22.
9
Beta-blockers in hypertension: how to get the best results.β受体阻滞剂用于治疗高血压：如何获得最佳疗效。
Drugs. 1979 Feb;17(2):129-33. doi: 10.2165/00003495-197917020-00004.
10
[Beta-adrenergic blockade and function of the respiratory system (author's transl)].β-肾上腺素能阻断与呼吸系统功能（作者译）
Munch Med Wochenschr. 1973 Sep 21;115(38):1612-6.
引用本文的文献
1
The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction.β受体阻滞剂在射血分数降低的心力衰竭中的应用
J Cardiovasc Dev Dis. 2021 Aug 24;8(9):101. doi: 10.3390/jcdd8090101.
2
Safety considerations in treating concomitant diseases in patients with asthma.哮喘患者合并疾病治疗中的安全考量
Drug Saf. 1998 May;18(5):357-68. doi: 10.2165/00002018-199818050-00005.
3
Stereoisomers and drug toxicity. The value of single stereoisomer therapy.立体异构体与药物毒性。单一立体异构体疗法的价值。
Drug Saf. 1993 Feb;8(2):149-59. doi: 10.2165/00002018-199308020-00005.
4
Treating mild hypertension.治疗轻度高血压。
Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):89-90. doi: 10.1136/bmj.291.6488.89.
5
Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension.
Eur J Clin Pharmacol. 1988;34(6):605-11. doi: 10.1007/BF00615225.
6
[How many beta-receptor blockers does the physician need?].医生需要多少种β受体阻滞剂？
Klin Wochenschr. 1987 Mar 16;65(6):289-95. doi: 10.1007/BF01773455.
7
Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.部分激动剂活性对慢性稳定性心绞痛患者β受体阻滞剂副作用的影响。
Drugs. 1989;38 Suppl 2:39-44. doi: 10.2165/00003495-198900382-00009.
本文引用的文献
1
Reduction of liver blood flow and propranolol metabolism by cimetidine.西咪替丁对肝血流量及普萘洛尔代谢的影响
N Engl J Med. 1981 Mar 19;304(12):692-5. doi: 10.1056/NEJM198103193041202.
2
A comparison of the effects of propranolol and oxprenolol on forearm blood flow and skin temperature.普萘洛尔和氧烯洛尔对前臂血流量及皮肤温度影响的比较。
Br J Clin Pharmacol. 1981 May;11(5):485-90. doi: 10.1111/j.1365-2125.1981.tb01154.x.
3
Antihypertensive drugs and blood lipids: the Oslo study.抗高血压药物与血脂：奥斯陆研究
Br J Clin Pharmacol. 1982;13(Suppl 2):441S-444S. doi: 10.1111/j.1365-2125.1982.tb01954.x.
4
Pindolol--the pharmacology of a partial agonist.吲哚洛尔——一种部分激动剂的药理学
Br J Clin Pharmacol. 1982;13(Suppl 2):149S-158S. doi: 10.1111/j.1365-2125.1982.tb01904.x.
5
6
Should every survivor of a heart attack be given a beta-blocker? Part I. Evidence from clinical trials.每位心脏病发作幸存者都应服用β受体阻滞剂吗？第一部分。来自临床试验的证据。
Br Med J (Clin Res Ed). 1982 Jul 3;285(6334):33-6. doi: 10.1136/bmj.285.6334.33.
7
Running performance as a function of the dose-response relationship to beta-adrenoceptor blockade.跑步表现与β-肾上腺素能受体阻滞剂剂量反应关系的函数
Int J Sports Med. 1982 Feb;3(1):29-32. doi: 10.1055/s-2008-1026058.
8
Jogger's blockade.慢跑者阻滞
Br Med J (Clin Res Ed). 1982 Feb 20;284(6315):532-3. doi: 10.1136/bmj.284.6315.532.
9
An investigation of the comparative liposolubilities of beta-adrenoceptor blocking agents.β-肾上腺素能受体阻滞剂的比较脂溶性研究。
J Pharm Pharmacol. 1981 Mar;33(3):172-3. doi: 10.1111/j.2042-7158.1981.tb13743.x.
10
Review of a review. Partial agonist activity of beta-adrenoceptor blocking drugs.
Eur Heart J. 1981 Jun;2(3):253-5. doi: 10.1093/oxfordjournals.eurheartj.a061203.
Zotero 插件